Behind every name for a product or drug is someone writing hundreds of possible names. Lieba Golden-Koulendros made a career out of it.

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $30.00. The company’s shares ...

Years of scouring the bush and breeding work at The University of Queensland have resulted in new varieties of a native Australian plant valuable to the global pharmaceutical industry ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target of $70.00. The company’s shares closed yesterday at ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

The groundbreaking technology delivering live beneficial bacteria to the skin is complementary to Young's line of medically formulated products," according to John Kulesza, Young Pharmaceuticals ...

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO) is pleased to announce the opening of the first clinical site for its lead asset, HG-CT-1, targeting relapsed ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

Yunnan Baiyao Group Co. Ltd. A 0.61% ¥102.33B Tasly Pharmaceutical Group Co. Ltd. A 0.07% ¥21.56B Jiangsu Hengrui Medicine Co. Ltd. A 1.55% ¥283.44B Zhejiang Hisun Pharmaceutical Co. Ltd. A 0. ...

SAN RAFAEL, Calif., Jan. 13, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has initiated a legal action against Ascendis Pharma A/S for ...

The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.